.png){kind=logo}
About JBP
With a good command of updated scientific technologies, JBP (Japan Bio Products Co., Ltd. ), is the world leading company in the area of the placenta-based products where JBP is further responsible to solve the questions still pending as to the composition and mechanism of the placenta, and for the effective application of various features of placenta in the sphere of medical treatment, health and beauty culture.
JBP History
1958
1967
1970
1971
1974
1975
1984
1996
1998
2004
2005
2006
2007
2011
2015
2016
2017
2018
2025
December: Laennec manufacturing approval / indication “Liver Cirrhosis”
July: listed in the National Health Insurance Drug Price List
October: Japan Bio Products Co., Ltd. established (capital: JPY 5,000,000)
December: Capital increased by JPY 20,000,000
January: Authorized capital: 160,000 shares (JPY 80,000,000)
March: Higashikushihara Plant established in Kurume City
August: Capital increased by JPY 45,000,000
October: New Nonaka Plant established in Kurume City
October: Drug efficacy re-evaluation announced; indication expanded to “Improvement of liver function in chronic liver diseases”
May: New factory completed in Kurume City
JBP Taiwan Co., Ltd. established
April: PARI (Placenta & Aloe Research Institute) established (present Research Institute)
February: JBP Korea Co., Ltd. established
April: Eumseong Plant in Korea completed
September: JBP China Co., Ltd. established
September: Merged with subsidiary Japan Bioproducts Co., Ltd.
September: Absorbed subsidiary Nissei Soken Co., Ltd.; capital JPY 55,000,000
April: New factory “L’Atelier Fujimitsu” completed in Fujimitsu-machi, Kurume City
June: Capital increased by JPY 25,000,000
June: JBP Nanoneedle Domestic Sales Approval Obtained
October: JBP Nanoneedle Pro Domestic Sales Approval Obtained
55th Anniversary Bridging to the Future -JBP55th-
